Subbu Nambi

Stock Analyst at Guggenheim

(4.39)
# 1,437
Out of 4,479 analysts
16
Total ratings
83.33%
Success rate
14.12%
Average return

12 Stocks

Guardant Health
Jun 28, 2024
Upgrades: Buy
Price Target: $36
Current: $28.87
Upside: +24.70%
Nautilus Biotechnology
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $2.27
Upside: +164.32%
10x Genomics
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $18.87
Upside: -
Repligen
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $120.14
Upside: -
Twist Bioscience
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $47.32
Upside: +12.00%
Castle Biosciences
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $21.26
Upside: +17.59%
Myriad Genetics
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $24.76
Upside: -7.11%
Natera
Dec 14, 2023
Initiates: Buy
Price Target: $70
Current: $110.70
Upside: -36.77%
Exact Sciences
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $43.17
Upside: +108.48%
Pacific Biosciences of California
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Illumina
Dec 14, 2023
Initiates: Buy
Price Target: $155
Current: $105.51
Upside: +46.91%
Akoya Biosciences
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.18
Upside: -